LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
US Stock MarketDetailed Quotes
SMLR Semler Scientific
- 42.920
- +2.290+5.64%
Close Feb 28 16:00 ET
- 42.210
- -0.710-1.65%
Post 20:01 ET
411.86MMarket Cap8.37P/E (TTM)
42.950High39.560Low420.71KVolume40.030Open40.630Pre Close17.53MTurnover5.32%Turnover Ratio8.37P/E (Static)9.60MShares81.55552wk High1.78P/B339.55MFloat Cap20.88052wk Low--Dividend TTM7.91MShs Float153.210Historical High--Div YieldTTM8.34%Amplitude1.120Historical Low41.670Avg Price1Lot Size
Semler Scientific Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -17.44%56.29M | -17.56%12.41M | -17.19%13.51M | -22.25%14.47M | -12.65%15.9M | 20.28%68.18M | 9.15%15.06M | 16.15%16.32M | 25.47%18.61M | 29.89%18.21M |
| Operating revenue | -17.44%56.29M | -17.56%12.41M | -17.19%13.51M | -22.25%14.47M | -12.65%15.9M | 20.28%68.18M | 9.15%15.06M | 16.15%16.32M | 25.47%18.61M | 29.89%18.21M |
| Cost of revenue | -31.86%4.76M | -67.44%1.1M | 4.05%1.16M | 2.95%1.26M | -1.73%1.25M | 64.25%6.98M | 186.38%3.39M | -2.37%1.11M | 26.58%1.22M | 30.82%1.27M |
| Gross profit | -15.79%51.54M | -3.09%11.31M | -18.74%12.36M | -24.02%13.21M | -13.47%14.66M | 16.72%61.2M | -7.46%11.67M | 17.79%15.21M | 25.39%17.39M | 29.83%16.94M |
| Operating expense | -19.91%30.6M | -13.82%7.77M | -12.23%7.29M | -22.99%7.86M | -28.10%7.68M | 8.46%38.21M | 0.21%9.02M | -1.60%8.31M | 17.49%10.21M | 17.32%10.68M |
| Selling and administrative expenses | -20.43%25.81M | -13.67%6.74M | -14.41%6.11M | -23.97%6.42M | -27.72%6.54M | 6.62%32.44M | 2.32%7.81M | -0.90%7.13M | 10.92%8.44M | 13.45%9.05M |
| -Selling and marketing expense | -27.93%13.08M | -34.65%2.97M | -13.06%2.98M | -30.67%3.46M | -29.22%3.68M | 2.61%18.15M | -2.32%4.55M | -17.58%3.42M | 18.66%4.99M | 11.04%5.19M |
| -General and administrative expense | -10.90%12.73M | 15.57%3.77M | -15.66%3.13M | -14.31%2.96M | -25.71%2.87M | 12.19%14.29M | 9.57%3.26M | 21.84%3.71M | 1.38%3.46M | 16.87%3.86M |
| Research and development costs | -16.99%4.79M | -14.83%1.03M | 1.02%1.19M | -18.27%1.44M | -30.18%1.14M | 20.05%5.77M | -11.58%1.21M | -5.63%1.17M | 64.06%1.76M | 44.76%1.63M |
| Operating profit | -8.95%20.93M | 33.31%3.54M | -26.57%5.07M | -25.49%5.35M | 11.51%6.98M | 33.64%22.99M | -26.54%2.66M | 54.42%6.9M | 38.66%7.18M | 58.70%6.26M |
| Net non-operating interest income expense | -24.04%1.88M | -74.39%179K | -75.72%168K | 19.60%714K | 69.21%819K | 400.20%2.47M | 103.79%699K | 405.11%692K | 4,492.31%597K | 48,300.00%484K |
| Non-operating interest income | -24.04%1.88M | -74.39%179K | -75.72%168K | 19.60%714K | 69.21%819K | 400.20%2.47M | 103.79%699K | 405.11%692K | 4,492.31%597K | 48,300.00%484K |
| Other net income (expense) | 1,942.32%25.07M | 5,423.80%28.86M | 289.70%1.14M | -4,338.74%-4.93M | 101.87%2K | -27,120.00%-1.36M | -17,966.67%-542K | -19,966.67%-602K | -111K | -107K |
| Gain on sale of security | 141.69%128K | ---- | ---- | 215.32%128K | ---- | ---307K | ---90K | ---- | ---111K | ---107K |
| Special income (charges) | --0 | --0 | --0 | ---- | ---- | ---1.07M | ---472K | ---599K | ---- | ---- |
| -Less：Restructuring and merger&acquisition | --0 | --0 | --0 | ---- | ---- | --734K | --135K | --599K | ---- | ---- |
| -Write off | --0 | --0 | ---- | ---- | ---- | --337K | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | 146,641.18%24.95M | 144,175.00%28.86M | 38,166.67%1.14M | ---5.06M | --2K | 440.00%17K | 766.67%20K | 0.00%-3K | ---- | ---- |
| Income before tax | 98.69%47.88M | 1,057.64%32.58M | -8.77%6.38M | -85.17%1.14M | 17.55%7.8M | 36.22%24.1M | -28.89%2.81M | 51.88%6.99M | 47.68%7.67M | 68.22%6.63M |
| Income tax | 98.61%6.99M | 339.52%3.37M | -48.03%766K | -36.99%1.13M | 3.61%1.72M | 4.46%3.52M | -289.88%-1.41M | 59.18%1.47M | 59.98%1.79M | 185.42%1.66M |
| Net income | 98.70%40.9M | 591.92%29.21M | 1.72%5.61M | -99.81%11K | 22.22%6.07M | 43.69%20.58M | 31.25%4.22M | 50.04%5.51M | 44.31%5.88M | 47.89%4.97M |
| Net income continuous Operations | 98.70%40.9M | 591.92%29.21M | 1.72%5.61M | -99.81%11K | 22.22%6.07M | 43.69%20.58M | 31.25%4.22M | 50.04%5.51M | 44.31%5.88M | 47.89%4.97M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 98.70%40.9M | 591.92%29.21M | 1.72%5.61M | -99.81%11K | 22.22%6.07M | 43.69%20.58M | 31.25%4.22M | 50.04%5.51M | 44.31%5.88M | 47.89%4.97M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 98.70%40.9M | 591.92%29.21M | 1.72%5.61M | -99.81%11K | 22.22%6.07M | 43.69%20.58M | 31.25%4.22M | 50.04%5.51M | 44.31%5.88M | 47.89%4.97M |
| Basic earnings per share | 84.97%5.66 | 487.10%3.64 | -2.44%0.8 | -99.82%0.0016 | 18.92%0.88 | 43.66%3.06 | 29.17%0.62 | 49.09%0.82 | 46.67%0.88 | 48.00%0.74 |
| Diluted earnings per share | 95.06%5.13 | 520.00%3.41 | 1.41%0.72 | -99.81%0.0014 | 23.81%0.78 | 46.93%2.63 | 34.15%0.55 | 54.35%0.71 | 47.06%0.75 | 53.66%0.63 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Trending Stocks
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call